Delivery Order SPE2DB20D3103-SPE2DB23FP4F5

Award Date 8/18/23
Potential Completion Date 9/11/23
Potential Value $10K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $8,550 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 vials of Xeomin. The contract has a period of performance from July 13, 2023 through August 3, 2023 and will be performed in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will supply the botulinum toxin Type A injection to the Defense Logistics Agency in support of its medical materiel procurement programs. No...
The Defense Logistics Agency awarded a $9,288.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562199420 units of Xeomin 100 unit vials. As the prime contractor, Amerisourcebergen will deliver the botulinum toxin type A injection to its place of performance in Conshohocken, Pennsylvania by October 6, 2023 to support Department of Defense requirements. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA...
The Defense Logistics Agency awarded a $1,572 delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. To be performed in Conshohocken, Pennsylvania under firm fixed price terms, the order runs from August 8th to August 29th, 2023. As a leading supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will deliver the botulinum toxin under this short-term requirement to support the Agency's medical readiness and logistics programs. No...
The Defense Logistics Agency awarded a $10,484.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 units of Xeomin, a botulinum toxin used for medical purposes. Performance will take place in Conshohocken, Pennsylvania over a four week period concluding in mid-September 2023. The prime contractor, Amerisourcebergen Drug Corporation, will supply the botulinum toxin products to the DLA, the Department of Defense's logistics combat support agency, in support of the...
The Defense Logistics Agency awarded a $8,092.40 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the purchase of 100 units of Xeomin 100 unit vials. The prime contractor will deliver the botulinum toxin type A injection product to the specified location in Conshohocken, Pennsylvania by August 24, 2023 to support Defense Logistics Agency programs. No subcontractors or set aside designations were identified for this delivery order placed under an...
The Defense Logistics Agency Troop Support Medical awarded a $31,454 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. The place of performance is Conshohocken, Pennsylvania. The period of performance is from September 26, 2023 through October 18, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will deliver botulinum toxin type A to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $855 to Amerisourcebergen Drug Corporation to supply 50 vials of Xeomin. As the prime contractor, Amerisourcebergen will deliver the botulinum toxin to a facility in Conshohocken, Pennsylvania under a September to October 2023 period of performance. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely procures pharmaceuticals and medical supplies to support...
The Defense Logistics Agency awarded a $5,471.20 firm fixed price delivery order to Amerisourcebergen Drug Corp for 50 units of Xeomin 50 unit vials. Performance will take place in Conshohocken, Pennsylvania, with no set-aside designation specified. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will provide the botulinum toxin injection vials in support of the Defense Logistics Agency's medical supply procurement programs. The delivery order was awarded on...
The Defense Logistics Agency awarded a $40,462 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. The contract has a period of performance from August 28, 2023 through September 19, 2023, with performance taking place in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corporation will deliver the botulinum toxin under this contract as the prime contractor, with oversight from the Defense Logistics Agency. No subcontractors or set aside...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,718.16 to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. Performance will take place in Conshohocken, Pennsylvania over a three week period concluding on August 1, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for the botulinum toxin appears to support routine medical needs. No subcontractors or set-aside designations were indicated.
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP4F5
    Delivery Order

The Defense Logistics Agency awarded a $10,484.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. The order is to be performed in Conshohocken, Pennsylvania from August 18th through September 11th, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will supply the botulinum toxin type A injection to the Defense Logistics Agency, the logistics combat support agency of the United States Department of Defense, in support of its medical supply programs. No subcontractors or set aside designations were indicated.

Generated 12/22/23, 4:31 PM